MXB-005（Maxwell Biosciences）

N/A

Report date: 2024/11/07 16:30:15
NME

Base Information

Drug NameMXB-005（Maxwell Biosciences）
Drug Alias NameMXB-5MXB-005
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionRecombinant envelope protein inhibitors
TargetsRecombinant envelope protein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Herpes LabialisHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxwell Biosciences IncUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesMaxwell Biosciences IncUniversity Of Louisville
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Herpes LabialisHerpes Simplex
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A